Experts discuss PPI use for GI protection in patients on antithrombotics, highlighting risk factors, dosing, drug ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

Millions of people worldwide take proton pump inhibitors (PPIs) to relieve heartburn, acid reflux, and gastroesophageal ...

People with acid reflux often rely on acid-reducing medications to ease symptoms. Depending on the severity of your symptoms, ...

As gastroenterology research progresses, it is critical to comprehend the connection between stomach cancer and gastric ...

Objective To determine whether new users of proton pump inhibitors (PPIs ... PPIs are one of the most commonly prescribed drug classes worldwide, and uncertainties relating to their association with ...

Acid peptic disorders are the result of distinctive, but overlapping pathogenic mechanisms leading to either excessive acid secretion ... a discussion of medications targeting gastric acid ...

Share on Pinterest A new study compares the risks and benefits of using GLP-1 medications ... paralysis of the stomach. “We think this is important — people taking GLP-1s and doctors ...

Heartburn and acid reflux are common during chemotherapy ("chemo"), caused by cancer drugs subsequently attacking cells of the stomach and esophagus (feeding ... Numico G, Fusco V, Franco P, Roila F.

Based on the perceived low efficacy of current therapies targeted to FGFR2 in gastric cancer (GC), the authors investigate an approach which combines SHP2 inhibition with existing FGFR2 inhibitors.